Unlocking causes and prevention methods for Alzheimer’s Disease
At the Feinstein Institute, we are committed to uncovering new ways to detect and treat Alzheimer’s disease – a condition that has the potential to nearly triple by 2050, as a large portion of the population will be over the age of 65. Our researchers in the Feinstein Institute’s Litwin-Zucker Center for Alzheimer’s Disease and Memory Disorders are using the latest genetic and neural imaging techniques to study the indicators and causes of Alzheimer’s disease. Through these discoveries we can better understand how to detect and prevent the disease. Combined with drug trials of the latest therapies, the Center is motivated to improve the lives of patients suffering from Alzheimer’s disease now and prevent cases in the future.